Works matching DE "AVATROMBOPAG"

Results: 61

血小板生成素受体激动剂致血栓栓塞不良事件的真实世界药物警戒研究.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 6, p. 755, doi. 10.14009/j.issn.1672-2124.2025.06.023

By:

谷文睿;
枉前;
郎晓琴

Publication type:

Article

Efficacy and safety of immunosuppressive therapy versus cyclosporine combined with avatrombopag in older adults with severe aplastic anemia: a multicenter prospective study.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01328-3

By:

Wang, Leyu;
Ye, Lei;
Zhao, Xin;
Chen, Miao;
Zhang, Fengkui;
Han, Bing

Publication type:

Article

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK.

Published in:

Journal of Market Access & Health Policy, 2025, v. 13, n. 2, p. 11, doi. 10.3390/jmahp13020011

By:

Cooper, Nichola;
Guterres, Sebastian;
Pochopień, Michał;
Wilson, Koo;
James, Sam;
Toumi, Mondher;
Tytuła, Anna;
Rich, Carly;
Eriksson, Daniel

Publication type:

Article

Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00873-8

By:

Wang, Xiaoling;
Li, Yunsong;
Zhuang, Wei

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 188, doi. 10.1002/cpdd.349

By:

Nomoto, Maiko;
Pastino, Gina;
Rege, Bhaskar;
Aluri, Jagadeesh;
Ferry, Jim;
Han, David

Publication type:

Article

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.

Published in:

2023

By:

Abdelsamia, Mahmoud;
Farid, Saira;
Dean, Steven;
Cataland, Spero R.

Publication type:

Case Study

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease.

Published in:

Journal of Blood Medicine, 2019, v. 11, p. 313, doi. 10.2147/JBM.S191790

By:

Cheloff, Abraham Z;
Al-Samkari, Hanny

Publication type:

Article

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2224044

By:

Wan, Ziqi;
Chen, Miao;
Han, Bing

Publication type:

Article

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2023.2195016

By:

Jain, Shivi;
Gernsheimer, Terry;
Kolodny, Scott;
Bernheisel, Chelsea;
Vredenburg, Michael;
Panch, Sandhya R.

Publication type:

Article

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2023.2195016

By:

Jain, Shivi;
Gernsheimer, Terry;
Kolodny, Scott;
Bernheisel, Chelsea;
Vredenburg, Michael;
Panch, Sandhya R.

Publication type:

Article

Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.

Published in:

2022

By:

Arif, Abdul Rehman;
Zhao, Miaomiao;
Chen, Wenlan;
Xue, Mei;
Luo, Shanshan;
Wang, Yadan

Publication type:

Case Study

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.

Published in:

Platelets, 2022, v. 33, n. 7, p. 1024, doi. 10.1080/09537104.2022.2026910

By:

Gao, Yanting;
Liu, Qi;
Shen, Yingying;
Li, Yuzhu;
Shao, Keding;
Ye, Baodong;
Shen, Yiping;
Zhou, Yuhong;
Wu, Dijiong

Publication type:

Article

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension.

Published in:

Platelets, 2022, v. 33, n. 2, p. 257, doi. 10.1080/09537104.2021.1881952

By:

Al‐Samkari, Hanny;
Nagalla, Srikanth

Publication type:

Article

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments.

Published in:

Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2230663

By:

Aiello, Andrea;
Mariano, Elisa Elena;
Prada, Mariangela;
Teruzzi, Cristina;
Martone, Nicoletta;
Capri, Stefano;
Carli, Giuseppe;
Siragusa, Sergio

Publication type:

Article

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.

Published in:

Biomedical Reports, 2024, v. 20, n. 3, p. N.PAG, doi. 10.3892/br.2024.1732

By:

Shen, Nan;
Qiao, Jibing;
Jiang, Yazhou;
Yan, Jingjing;
Wu, Rang;
Yin, Hanjun;
Zhu, Suyue;
Li, Jianqin

Publication type:

Article

Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US food and drug administration's adverse event reporting system.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62129-5

By:

Zhu, Hong;
Wu, Meng

Publication type:

Article

Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03659-8

By:

Hu, Huan;
Lei, Dongmei;
Liang, Yan

Publication type:

Article

Correction to: Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia.

Published in:: Gastroenterology Report, 2023, v. 11, p. 1, doi. 10.1093/gastro/goac086
Publication type:: Article

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia.

Published in:

Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goac059

By:

Biolato, Marco;
Vitale, Federica;
Marrone, Giuseppe;
Miele, Luca;
Grieco, Antonio

Publication type:

Article

Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 952, doi. 10.1111/bcp.13517

By:

Nomoto, Maiko;
Zamora, Cynthia A.;
Schuck, Edgar;
Boyd, Peter;
Chang, Min‐Kun;
Aluri, Jagadeesh;
Siu, Y. Amy;
Lai, W. George;
Yasuda, Sanae;
Ferry, Jim;
Rege, Bhaskar

Publication type:

Article

Avatrombopag Optimizes Response to Niraparib by Managing Thrombocytopenia Associated with Poly-ADP Ribose Polymerase (PARP) Inhibition in Ovarian Cancer and Breast Cancer: A Case Series.

Published in:

American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.927008

By:

Gabrail, Nash;
Smith, Carrie

Publication type:

Article

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives.

Published in:

Therapeutics & Clinical Risk Management, 2022, v. 18, p. 273, doi. 10.2147/TCRM.S251672

By:

Tsykunova, Galina;
Ghanima, Waleed

Publication type:

Article

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia.

Published in:

2022

By:

Tu, Xiaofang;
Xue, Ali;
Wu, Suye;
Jin, Mengmeng;
Zhao, Pu;
Zhang, Hao

Publication type:

Case Study

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1576053

By:

Sau, Antonella;
Di Prinzio, Gianfranco;
Onofrillo, Daniela;
Russo, Anna Caterina;
Santoro, Nicole;
Di Ianni, Mauro

Publication type:

Article

Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.

Published in:

International Journal of Hepatology, 2020, p. 1, doi. 10.1155/2020/5421632

By:

Poordad, Fred;
Terrault, Norah A.;
Alkhouri, Naim;
Tian, Wei;
Allen, Lee F.;
Rabinovitz, Mordechai

Publication type:

Article

The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence.

Published in:

International Journal of Hepatology, 2016, p. 1, doi. 10.1155/2016/1802932

By:

Qureshi, Kamran;
Patel, Shyam;
Meillier, Andrew

Publication type:

Article

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.

Published in:

Annals of Hematology, 2023, v. 102, n. 4, p. 715, doi. 10.1007/s00277-023-05114-8

By:

Pulanić, Dražen;
Bátorová, Angelika;
Bodó, Imre;
Červinek, Libor;
Ionita, Ioana;
Lissitchkov, Toshko;
Melikyan, Anahit;
Podolak-Dawidziak, Maria

Publication type:

Article

Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.

Published in:

2022

By:

Jiang, Ziming;
Jiang, Xianyong;
Chen, Miao

Publication type:

Letter

Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis.

Published in:

Annals of Hematology, 2022, v. 101, n. 5, p. 953, doi. 10.1007/s00277-022-04784-0

By:

Zhou, Huifeng;
Fan, Junjie;
He, Jie;
Hu, Shaoyan

Publication type:

Article

Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme.

Published in:

Medicina (1010660X), 2023, v. 59, n. 4, p. 659, doi. 10.3390/medicina59040659

By:

González-López, Tomás José;
Provan, Drew

Publication type:

Article

Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1393829

By:

Ting Zhang;
Qingling Yu;
Xiaoyu Chen;
Hui Yang;
Yuemin Gong;
Yawen Zhang;
Xiaoqing Liu;
Zhinan Yang;
Yu Fang;
Xue Yan;
Xuan Zhou;
Jinning Shi;
Guangsheng He

Publication type:

Article

Avatrombopag v léčbě trombocytopenií – lékový profi l přípravku Doptelet.

Published in:: Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 4, p. 273
Publication type:: Article

Avatrombopag v léčbě trombocytopenií – lékový profi l přípravku Doptelet.

Published in:: Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 4, p. 267
Publication type:: Article

Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.

Published in:

Transfusion, 2024, v. 64, n. 3, p. 510, doi. 10.1111/trf.17743

By:

Cao, Junjie;
Lu, Shaoyan;
Luo, Danjie;
Pei, Renzhi;
Lu, Ying;
Chen, Dong;
Du, Xiaohong;
Li, Shuangyue

Publication type:

Article

Safety of non-peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta-analysis of short-term double-blind randomized clinical trials.

Published in:

Experimental & Therapeutic Medicine, 2023, v. 26, n. 2, p. 1, doi. 10.3892/etm.2023.12092

By:

NAN SHEN;
JIBING QIAO;
YAZHOU JIANG;
HANJUN YIN;
MIN LI;
SUYUE ZHU;
JIANQIN LI

Publication type:

Article

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1009612

By:

Yong-Shuai Wang;
Wei Wang;
Sai Zhang;
Shen-Yu Zhang;
Ai-Zong Shen;
Hua-Chuan Song;
Huan-Zhang Yao;
Rui-Peng Song;
Fan-Zheng Meng;
Lei Li;
Nashan, Bjoern;
Ji-Zhou Wang;
Lian-Xin Liu

Publication type:

Article

Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.970978

By:

Yayun Cui;
Yifu He;
Changlu Hu;
Congyin Tu;
Jin Huang;
Xiaofeng Zhu;
Chunbao Zang;
Kaiyang Ding;
Bihong Zhan;
Yufei Zhao;
Liting Qian

Publication type:

Article

Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Study.

Published in:

Acta Haematologica, 2023, v. 146, n. 3, p. 173, doi. 10.1159/000528642

By:

Liu, Yin;
Zhang, Han-Xi;
Su, Juan;
Geng, Qing-Chao;
Lin, Xin;
Feng, Chen-Xi

Publication type:

Article

Long‐term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real‐world observational study.

Published in:

British Journal of Haematology, 2025, v. 206, n. 3, p. 935, doi. 10.1111/bjh.19973

By:

Wang, Nan;
Wang, Zhifa;
Liu, Jingjing;
Hu, Yu;
Dong, Shuyue;
Chen, Hui;
Meng, Jinxi;
Ma, Jingyao;
Chen, Zhenping;
Cheng, Xiaoling;
Wu, Runhui

Publication type:

Article

Avatrombopag in adults with immune thrombocytopenia: A multicentre real‐life observational study in Madrid, Spain (AVAMAD study).

Published in:

British Journal of Haematology, 2025, v. 206, n. 2, p. 652, doi. 10.1111/bjh.19975

By:

Pascual‐Izquierdo, Cristina;
Llacer‐Ferrandis, Mª. Jose;
de‐la‐Iglesia, Almudena;
Monsalvo‐Saornil, Silvia;
Menor‐Gómez, María;
Gil‐Fernández, Juan Jose;
Chica‐Gullon, Esther;
Álvarez‐Román, María Teresa;
Perez‐Segura, Gloria;
Zafra, Denis;
Ortuzar‐Pasalodos, Ariana;
González‐Gascón‐y‐Marín, Isabel Teresa;
Moreno, Gemma;
Arquero‐Portero, Teresa;
Moreno‐Carbonell, Marta;
Revilla, Nuria

Publication type:

Article

A second chance for avatrombopag in chemotherapy‐induced thrombocytopenia.

Published in:

British Journal of Haematology, 2025, v. 206, n. 1, p. 375, doi. 10.1111/bjh.19861

By:

Al‐Samkari, Hanny;
Moore, Donald C.

Publication type:

Article

Avatrombopag for the treatment of patients with chemotherapy‐induced thrombocytopenia: A case series.

Published in:

British Journal of Haematology, 2025, v. 206, n. 1, p. 272, doi. 10.1111/bjh.19797

By:

Galamaga, Robert;
Johnston, Stephanie;
Acosta, Cassaundra

Publication type:

Article

Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Published in:

British Journal of Haematology, 2024, v. 205, n. 6, p. 2414, doi. 10.1111/bjh.19800

By:

Tian, Hong;
Zhou, Lu;
Dai, Jia‐wen;
Li, Yun;
Gu, Cheng‐Yuan;
Kong, Dan‐Qing;
Yu, Zi‐Qiang;
Liu, Xiao‐fan;
Yin, Jie

Publication type:

Article

Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Published in:

British Journal of Haematology, 2024, v. 205, n. 6, p. 2414, doi. 10.1111/bjh.19800

By:

Tian, Hong;
Zhou, Lu;
Dai, Jia‐wen;
Li, Yun;
Gu, Cheng‐Yuan;
Kong, Dan‐Qing;
Yu, Zi‐Qiang;
Liu, Xiao‐fan;
Yin, Jie

Publication type:

Article

Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia.

Published in:

British Journal of Haematology, 2024, v. 205, n. 4, p. 1551, doi. 10.1111/bjh.19602

By:

Mingot‐Castellano, Maria Eva;
Bastida, Jose Maria;
Ghanima, Waleed;
Ruiz Sainz, Elena;
Nuñez Vazquez, Ramiro;
Pedrote Amador, Begoña;
Abdel‐Kader Martín, Laila;
Piquer‐Monsonis, Dolores;
Canaro, Mariana

Publication type:

Article

Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China.

Published in:

British Journal of Haematology, 2024, v. 204, n. 5, p. 1958, doi. 10.1111/bjh.19342

By:

Wang, Zhifa;
Zhang, Aijun;
Xu, Zhongjin;
Wang, Nan;
Zhang, Jialu;
Meng, Jinxi;
Dong, Shuyue;
Ma, Jingyao;
Hu, Yu;
Ouyang, Juntao;
Chen, Zhenping;
An, Qi;
Cheng, Xiaoling;
Wu, Runhui

Publication type:

Article

A phase 3, randomized, double‐blind, active‐controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 897, doi. 10.1111/bjh.18908

By:

Tarantino, Michael D.;
Bussel, James B.;
Lee, Eun‐Ju;
Jamieson, Brian D.

Publication type:

Article

Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials.

Published in:

British Journal of Haematology, 2023, v. 202, n. 4, p. 890, doi. 10.1111/bjh.18897

By:

Bussel, James B.;
Tarantino, Michael D.;
Lee, Eun‐Ju;
Jamieson, Brian D.

Publication type:

Article

Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real‐world study in China.

Published in:

British Journal of Haematology, 2023, v. 202, n. 3, p. 636, doi. 10.1111/bjh.18864

By:

Cheng, Xiaoling;
Wang, Zhifa;
Dong, Shuyue;
Ma, Jingyao;
Meng, Jinxi;
Wang, Xiaoling;
Wu, Runhui

Publication type:

Article

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.

Published in:

British Journal of Haematology, 2022, v. 197, n. 3, p. 359, doi. 10.1111/bjh.18081

By:

Al‐Samkari, Hanny;
Jiang, Debbie;
Gernsheimer, Terry;
Liebman, Howard;
Lee, Susie;
Wojdyla, Matthew;
Vredenburg, Michael;
Cuker, Adam

Publication type:

Article